{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:41:12Z","timestamp":1793727672539,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004233","name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","doi-asserted-by":"publisher","award":["ACIF\/2018\/153"],"award-info":[{"award-number":["ACIF\/2018\/153"]}],"id":[{"id":"10.13039\/501100004233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004233","name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","doi-asserted-by":"publisher","award":["CIAICO\/2021\/061"],"award-info":[{"award-number":["CIAICO\/2021\/061"]}],"id":[{"id":"10.13039\/501100004233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004233","name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","doi-asserted-by":"publisher","award":["PID2020-115010RB-I00"],"award-info":[{"award-number":["PID2020-115010RB-I00"]}],"id":[{"id":"10.13039\/501100004233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004233","name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","doi-asserted-by":"publisher","award":["PID2022-1381890NB-I00"],"award-info":[{"award-number":["PID2022-1381890NB-I00"]}],"id":[{"id":"10.13039\/501100004233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115593","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:35:47Z","timestamp":1696224947000},"page":"115593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of the PARP inhibitor talazoparib photosafety profile"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-7162","authenticated-orcid":false,"given":"Alejandro","family":"Mateos-Pujante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Consuelo","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3409-9443","authenticated-orcid":false,"given":"Inmaculada","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115593_bib1","first-page":"97","article-title":"Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death","volume":"477","author":"Herceg","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2023.115593_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3240","article-title":"A systematic analysis of the PARP protein family identifies new functions critical for cell physiology","volume":"4","author":"Vyas","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115593_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.sbi.2018.11.002","article-title":"PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification","volume":"53","author":"Langelier","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biopha.2023.115593_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115593_bib5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/emboj\/cdg206","article-title":"Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse","volume":"22","author":"M\u00e9nissier de Murcia","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.115593_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acs.jmedchem.5b01498","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115593_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11523-021-00796-4","article-title":"An overview of PARP inhibitors for the treatment of breast cancer","volume":"16","author":"Cortesi","year":"2021","journal-title":"Target. Oncol."},{"key":"10.1016\/j.biopha.2023.115593_bib8","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.115593_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05031-9","article-title":"Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance","volume":"9","author":"Michelena","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115593_bib10","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s40265-018-1026-z","article-title":"Talazoparib: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.115593_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115593_bib12","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1634\/theoncologist.2019-0493","article-title":"Talazoparib in patients with a germline BRCA-mutated advanced breast cancer: detailed safety analyses from the phase III EMBRACA trial","volume":"25","author":"Hurvitz","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2023.115593_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22678","article-title":"Proteomic analysis of talazoparib resistance in triple-negative breast cancer cells","volume":"35","author":"Guney Eskiler","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2023.115593_bib14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jcph.1415","article-title":"A phase 1 mass balance study of (14) C-labeled talazoparib in patients with advanced solid tumors","volume":"59","author":"Yu","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115593_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40268-020-00301-8","article-title":"Poly (ADP-Ribose) polymerase inhibitors: talazoparib in ovarian cancer and beyond","volume":"20","author":"Boussios","year":"2020","journal-title":"Drugs R. D."},{"key":"10.1016\/j.biopha.2023.115593_bib16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S1470-2045(21)00376-4","article-title":"Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial","volume":"22","author":"de Bono","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2023.115593_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22022-4","article-title":"Radiosensitization effect of talazoparib, a parp inhibitor, on glioblastoma stem cells exposed to low and high linear energy transfer radiation","volume":"8","author":"Lesueur","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115593_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00353","article-title":"Nanoformulation of talazoparib delays tumor progression and ascites formation in a late stage cancer model","volume":"9","author":"Baldwin","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.115593_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-07319-9","article-title":"Evaluation of phototoxicity induced by the anticancer drug rucaparib","volume":"12","author":"Mateos-Pujante","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115593_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan Blue Exclusion Test of Cell Viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.biopha.2023.115593_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1139\/v97-048","article-title":"Quinones and hydroxyquinones as generators and quenchers of singlet molecular oxygen","volume":"75","author":"Guti\u00e9rrez","year":"1997","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.biopha.2023.115593_bib22","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 432: In Vitro 3T3 NRU Phototoxicity Test, OECD Guidelines for the Testing of Chemicals, Section 4, (2019). https:\/\/doi.org\/10.1787\/9789264071162-en.","DOI":"10.1787\/9789264071162-en"},{"key":"10.1016\/j.biopha.2023.115593_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/abd1806-4841.20197620","article-title":"Human keratinocyte cell line as a suitable model for in vitro phototoxicity testing","volume":"94","author":"Svobodov\u00e1","year":"2019","journal-title":". Bras. Dermatol."},{"key":"10.1016\/j.biopha.2023.115593_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jphotobiol.2015.12.001","article-title":"Photosensitized rose Bengal-induced phototoxicity on human melanoma cell line under natural sunlight exposure","volume":"156","author":"Srivastav","year":"2016","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"10.1016\/j.biopha.2023.115593_bib25","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1039\/C4AY00288A","article-title":"Measurement of DCF fluorescence as a measure of reactive oxygen species in murine islets of Langerhans","volume":"6","author":"Wang","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.biopha.2023.115593_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jchromb.2015.11.052","article-title":"A step-by-step protocol for assaying protein carbonylation in biological samples","volume":"1019","author":"Colombo","year":"2016","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.biopha.2023.115593_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.taap.2016.10.024","article-title":"Enhanced photo(geno)toxicity of demethylated chlorpromazine metabolites","volume":"313","author":"Palumbo","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115593_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mrrev.2005.10.001","article-title":"Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA","volume":"612","author":"M\u00f8ller","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2023.115593_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2018.01.005","article-title":"Photo(geno)toxicity changes associated with hydroxylation of the aromatic chromophores during diclofenac metabolism","volume":"341","author":"Garcia-Lainez","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115593_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/j100820a009","article-title":"Quantum efficiences of fluorescence of organic substances: effect of solvent and concentration of the fluorescent solute","volume":"65","author":"Melhuish","year":"1961","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.biopha.2023.115593_bib31","series-title":"Handbook of Photochemistry","author":"Marco Montalti","year":"2006"},{"key":"10.1016\/j.biopha.2023.115593_bib32","first-page":"163","article-title":"The comet assay. Principles, applications, and limitations","volume":"203","author":"Collins","year":"2002","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2023.115593_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-013-1070-0","article-title":"The essential comet assay: a comprehensive guide to measuring DNA damage and repair","volume":"87","author":"Azqueta","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2023.115593_bib34","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00204-016-1767-y","article-title":"Comet assay: an essential tool in toxicological research","volume":"90","author":"Glei","year":"2016","journal-title":"Arch. Toxicol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:41:46Z","timestamp":1776462106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"alternative-id":["S0753332223013914"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115593","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the PARP inhibitor talazoparib photosafety profile","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115593"}}